The François Jacob Institute of Biology brings together five departments and three services
The last two years in scientific news
Scientific result | Highlight | Infectious diseases
Preclinical trials carried out as part of a CEA-Irig–CEA-Jacob partnership have shown that a spike-protein-based candidate vaccine provides complete protection against SARS-CoV-2 infection. The team's work has been published in Cell Reports Medicine.
Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection | Cell Reports Medecine
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.